UNDERWRITING AGREEMENT between APIMEDS PHARMACEUTICALS US, INC. and as Representative of the Several Underwriters APIMEDS PHARMACEUTICALS US, INC.Underwriting Agreement • December 9th, 2024 • Apimeds Pharmaceuticals US, Inc. • Pharmaceutical preparations • New York
The undersigned, Apimeds Pharmaceuticals US, Inc., a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Apimeds Pharmaceuticals US, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with D. Boral Capital Securities, LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
